Summit set to inform electrophysiologists on Riata ICD lead recall

[Business Wire, January 07, 2012] Cardiovascular leaders will gather in Minneapolis for a one-day summit on Jan. 20, to review data for Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads, which recently underwent a Class I FDA recall.

The summit directors are Robert G. Hauser, MD, senior cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital and David L. Hayes, MD, professor of medicine. Read more at

Share this article